Skip to main content
Top
Published in: Annals of Behavioral Medicine 2/2012

01-04-2012 | Invited Commentary

Commentary: Benefits of Adherence to Psychotropic Medications on Depressive Symptoms and Antiretroviral Medication Adherence Among HIV-Positive Men and Women

Author: Ashraf Kagee

Published in: Annals of Behavioral Medicine | Issue 2/2012

Login to get access

Excerpt

With the availability of antiretroviral therapy in the last 20 years, the expected life span of persons living with HIV is now comparable to those living with any other chronic illness. Yet, high levels of adherence to antiretroviral therapy are necessary to ensure favourable treatment outcomes such as a supressed viral load, slower disease progression, fewer opportunistic infections and decreased mortality rates [1]. In recent years, various barriers to optimal adherence have been identified, including symptoms of depression [2, 3, 5]. The article by Cruess et al. on the relationships among depressive symptoms, adherence to psychotropic medications and antiretroviral adherence is therefore both important and timely [4]. …
Literature
1.
go back to reference World Health Organization (2009). Towards universal access: Scaling up priority HIV/AIDS interventions in the health sector: Progress report. WHO: Geneva. World Health Organization (2009). Towards universal access: Scaling up priority HIV/AIDS interventions in the health sector: Progress report. WHO: Geneva.
2.
go back to reference Campos LN, Guimarães MD, Remien RH.(2010). Anxiety and depression symptoms as risk factors for non-adherence to antiretroviral therapy in Brazil. AIDS Behavior, 14, 289–99.CrossRef Campos LN, Guimarães MD, Remien RH.(2010). Anxiety and depression symptoms as risk factors for non-adherence to antiretroviral therapy in Brazil. AIDS Behavior, 14, 289–99.CrossRef
3.
go back to reference Ammassari, A., Antinori, A., Aloisi, M. S., Trotta, M. P., Murri, R., Bartoli, L., Monforte, A. A., Wu, A. W., & Starace, F. (2004). Depressive symptoms, neurocognitive impairment and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics, 45, 394–402. Retrieved from http://psy.psychiatryonline.org/cgi/reprint/45/5/394 Ammassari, A., Antinori, A., Aloisi, M. S., Trotta, M. P., Murri, R., Bartoli, L., Monforte, A. A., Wu, A. W., & Starace, F. (2004). Depressive symptoms, neurocognitive impairment and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics, 45, 394–402. Retrieved from http://​psy.​psychiatryonline​.​org/​cgi/​reprint/​45/​5/​394
4.
go back to reference Cruess, D.G., Kalichman, S.C., Amaral, C., Swetzes, C., Cherry, C., & Kalichman, M.O. (2011). Benefits of adherence to psychotropic medications on depressive symptoms and antiretroviral medication adherence among men and women living with HIV/AIDS. Annals of Behavioral Medicine doi:10.1007/s12160-011-9322-9. Cruess, D.G., Kalichman, S.C., Amaral, C., Swetzes, C., Cherry, C., & Kalichman, M.O. (2011). Benefits of adherence to psychotropic medications on depressive symptoms and antiretroviral medication adherence among men and women living with HIV/AIDS. Annals of Behavioral Medicine doi:10.​1007/​s12160-011-9322-9.
6.
go back to reference Safren, S. A., O’Cleirigh, C. Tan, J. Y., Ramimani, S. R., Reilly, L. C., Otto, M. W., Mayer, K. H. (2009). A randomized controlled trial of cognitive behavioural therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychology, 28, 1–10.PubMedCrossRef Safren, S. A., O’Cleirigh, C. Tan, J. Y., Ramimani, S. R., Reilly, L. C., Otto, M. W., Mayer, K. H. (2009). A randomized controlled trial of cognitive behavioural therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychology, 28, 1–10.PubMedCrossRef
Metadata
Title
Commentary: Benefits of Adherence to Psychotropic Medications on Depressive Symptoms and Antiretroviral Medication Adherence Among HIV-Positive Men and Women
Author
Ashraf Kagee
Publication date
01-04-2012
Publisher
Springer-Verlag
Published in
Annals of Behavioral Medicine / Issue 2/2012
Print ISSN: 0883-6612
Electronic ISSN: 1532-4796
DOI
https://doi.org/10.1007/s12160-011-9327-4

Other articles of this Issue 2/2012

Annals of Behavioral Medicine 2/2012 Go to the issue